♦︎ Recorded: Friday, Nov 23, 2018
♦︎ Language: English
- JAMES STUART, Chair of CoMO’s Scientific Advisory Group, Consultant for the WHO, Honorary Professor at the University of Bristol and Chair of Meningitis Research Foundation's Scientific Advisory Panel, United Kingdom
- SAM NYE, Executive Director of the Confederation of Meningitis Organisations (CoMO), United Kingdom
- JANE PLUMB, MBE, Chief Executive of Group B Strep Support (GBSS), United Kingdom
♦︎ Learning Objectives: (1) Identify how and why meningitis vaccines have evolved and are still evolving (2) Recognise the importance of patient advocacy and the impact it has had on the development of existing and new vaccines (3) Learn what the future may hold for Group B strep vaccines
Prof James Stuart:
After qualifying in medicine, James worked as a clinical doctor in the UK and rural South Africa before specialising in public health. An infectious disease epidemiologist, James has been involved in outbreak investigation and control at an international level, and has published many papers on risk factors for meningococcal disease and carriage. Recently he has been working for WHO on meningitis control in subSaharan Africa.
Sam is the Executive Director of the Confederation of Meningitis Organisations (CoMO), an organisation that brings together meningitis organisations from around the world. Sam oversees all global CoMO projects and activities and is responsible for the day to day operation of CoMO.
Jane Plumb MBE:
Jane is the Chief Executive of Group B Strep Support, which she founded in 1996, with the objective of eradicating group B Strep infection in babies. GBSS exists to provide up to date and evidence based information on group B Strep to new and expectant parents and their health professionals, and to support to affected families.